ArticleScientific reports2025
Phytochemical profiling, biological potential and In Silico identification of anticancerous compound from Pakistani pomegranate Peel.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Enzyme Inhibition by Bioactive Compounds from Olive (Molecules (Basel, Switzerland) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The increasing antimicrobial resistance and recurrence is a major public health concern leading to high rates of morbidity and mortality worldwide. Furthermore, free radicals induced damage led to oxidative diseases such as cancer and diabetes.Therefore, finding safe and effective antimicrobial and antioxidant agents is vital. Pomegranate peel, constituting 60% of the total fruit's weight, is largely disposed despite its known benefits in traditional medicine. The current study aimed to determine the chemical constituents and biological activities of the methanolic extracts of peels of three pomegranate varieties [wild (PPE-1), white (PPE-2), and red (PPE-3)]. Phytochemicals analysis were performed using UV-vis spectrophotometry, gas chromatography-mass spectroscopy (GC-MS), and high-performance liquid chromatography (HPLC). The antioxidant potentials were determined via 2,2-diphenyl-1-picrylhydrazyl scavenging and phosphomolybdate (ABTS) assay and In Vitro antidiabetic activity was assessed by α-amylase inhibition assay. The antibacterial activity was assesed against three most dominant pathogens including E. coli, Staphylococcus aureus and Staphylococcus epidermidis by disc diffusion. The total phenolics, flavonoid, and tannin contents were highest in PPE-1 followed by PPE-2 and PPE-3. Among the polyphenol, chlorogenic acid was found in substantial concentration in all extracts. The GC-MS analysis identified 13 distinct compounds with the notable presence of 5-(hydroxymethyl) furan-2-carbaldehyde. All varieties exhibited significant antioxidants, antibacterial and antidiabetics, but the PPE-1 showed the highest activities. Docking studies revealed that chlorogenic acid was a strong inhibitor of Cyclooxygenase-II (COX-II) indicating anti-inflammatory and anticancerous potential. The study revealed that pomegranate peels have promising biological potentials such as antioxidants, antidiabetic, and antimicrobial, suggesting their role in drug developments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.